Linda Danielson has been Chief Operating Officer at the International Drug Development Institute (IDDI) since 2011. Linda obtained her M.S. degree in Biostatistics in 1990 from the University of Wisconsin, Madison. She has over 25 years of experience in the Pharmaceutical Industry and in the Clinical Trial environment. Prior to IDDI, Linda was the Head of Biostatistics at UCB Pharma Belgium. As COO, Linda directs the operational teams and the development, modification and evaluation of processes for providing Randomization, Clinical Data Management, Biostatistical and Project Management support for clinical trials. Linda has had a special interest in the relationship between Statistics and Randomization since the last 90's.